Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wedemeyer

Showing results (531-540 of 1,142) with videos related to

Pageof 115
Sort By:
Plos One|January 12, 2016
Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 StudiesHeiner Wedemeyer, Xavier Forns, Christophe Hézode, et al.
Journal of Hepatology|April 9, 2016
Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell functionSebastian Lunemann, Gloria Martrus, Angelique Hölzemer, et al.
Journal of Viral Hepatitis|February 20, 2016
Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cellsS A Drave, Y Debing, S Walter, et al.
Acta Gastro-Enterologica Belgica|February 17, 2015
Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinomaM M Kirstein, N Schweitzer, S Schmidt, et al.
Comparative Medicine|April 24, 2010
Echocardiographic assessment of cardiac morphology and function in XenopusHeather L Bartlett, Robert B Escalera, Sonali S Patel, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Critical Care Medicine|March 21, 2012
Angiopoietin-2 in acute liver failureJohannes Hadem, Clemens L Bockmeyer, Alexander Lukasz, et al.
Infection|December 18, 2007
Clearance of chronic HCV infection during acute delta hepatitisK Deterding, S V Pothakamuri, V Schlaphoff, et al.
JHEP Reports : Innovation in Hepatology|February 7, 2023
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infectionRani Burm, Freya Van Houtte, Lieven Verhoye, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patientsMartin Franck, Katharina John, Sherin Al Aoua, et al.
Pageof 115

Showing results (531-540 of 1,142) with videos related to

Sort By:
Pageof 115
Plos One|January 12, 2016
Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 StudiesHeiner Wedemeyer, Xavier Forns, Christophe Hézode, et al.
Journal of Hepatology|April 9, 2016
Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell functionSebastian Lunemann, Gloria Martrus, Angelique Hölzemer, et al.
Journal of Viral Hepatitis|February 20, 2016
Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cellsS A Drave, Y Debing, S Walter, et al.
Acta Gastro-Enterologica Belgica|February 17, 2015
Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinomaM M Kirstein, N Schweitzer, S Schmidt, et al.
Comparative Medicine|April 24, 2010
Echocardiographic assessment of cardiac morphology and function in XenopusHeather L Bartlett, Robert B Escalera, Sonali S Patel, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Critical Care Medicine|March 21, 2012
Angiopoietin-2 in acute liver failureJohannes Hadem, Clemens L Bockmeyer, Alexander Lukasz, et al.
Infection|December 18, 2007
Clearance of chronic HCV infection during acute delta hepatitisK Deterding, S V Pothakamuri, V Schlaphoff, et al.
JHEP Reports : Innovation in Hepatology|February 7, 2023
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infectionRani Burm, Freya Van Houtte, Lieven Verhoye, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patientsMartin Franck, Katharina John, Sherin Al Aoua, et al.
Pageof 115